Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
6.50
-0.03 (-0.38%)
At close: Mar 28, 2025, 4:00 PM
6.45
-0.05 (-0.77%)
After-hours: Mar 28, 2025, 7:27 PM EDT

Trevi Therapeutics Market Cap

Trevi Therapeutics has a market cap or net worth of $628.43 million as of March 28, 2025. Its market cap has increased by 231.35% in one year.

Market Cap
628.43M
Enterprise Value
521.84M
1-Year Change
231.35%
Ranking
Category
Stock Price
$6.50

Market Cap Chart

Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $628.43M, an increase of 639.43%. That is a compound annual growth rate of 40.40%.

History

DateMarket Cap% Change
Mar 28, 2025628.43M70.68%
Dec 31, 2024368.19M330.28%
Dec 29, 202385.57M-26.01%
Dec 30, 2022115.65M472.04%
Dec 31, 202120.22M-54.55%
Dec 31, 202044.48M-33.49%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings